Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #6887
Reference
MSAN(2020)37
Name
Valproate semisodium (Depakote®) 250mg and 500mg tablets
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
SUPPLIES
Description
1. Depakote® 250mg and 500mg tablets are out of stock until mid May 2020.
2. Limited supplies of Depakote® tablets are available from parallel import companies (see information below).
3. Syonell® (valproate semisodium) tablets are in stock and able to support the market during this time.
4. Belvo® (valproate semisodium) tablets are in stock and able to partially support the market during this time.
5. NOTE: information in this MSAN only applies to the use of valproate semisodium in licensed indications i.e. the treatment of manic episodes in bipolar disorder when lithium is contraindicated or not tolerated. The continuation of treatment after manic episodes could be considered in patients who have responded to valproate semisodium for acute mania.
2. Limited supplies of Depakote® tablets are available from parallel import companies (see information below).
3. Syonell® (valproate semisodium) tablets are in stock and able to support the market during this time.
4. Belvo® (valproate semisodium) tablets are in stock and able to partially support the market during this time.
5. NOTE: information in this MSAN only applies to the use of valproate semisodium in licensed indications i.e. the treatment of manic episodes in bipolar disorder when lithium is contraindicated or not tolerated. The continuation of treatment after manic episodes could be considered in patients who have responded to valproate semisodium for acute mania.
Contact Name
Contact Email
Contact Address
Created
2020-05-01 00:00:00
Click to go back to homepage